Skip to Content
Home > About Us > Research and Grants Administration > Results
The purpose of this study is to compare any good and bad effects of receiving the drugs dabrafenib and trametinib continuously to receiving dabrafenib and trametinib with a break in treatment for patients with BRAF mutant melanoma.
View Additional Section Content
For more information about our research program and IRB, please contact: